Today: 2 June 2026
Swarmer Soars 38% After Cramer Shouts Out Drone Software
2 June 2026
2 mins read

Swarmer Soars 38% After Cramer Shouts Out Drone Software

New York, June 2, 2026, 16:05 EDT

  • Swarmer finished the day at $78.52, rising 37.7%. Shares hit a new intraday high earlier at $83.30.
  • Military drone stocks saw new interest after Jim Cramer called Swarmer “a natural.”
  • The company’s revenue base is still small. Losses are widening and there’s execution risk with its defense contracts.

Swarmer Inc jumped 37.7% to $78.52 on Tuesday. The defense-tech company got new buying from retail traders and investors in drones. Shares opened at $56.38, touched $83.30 and saw volume more than double the normal pace—about 2.6 times average, according to Google Finance data.

Swarmer jumped out during a volatile day for Wall Street, with the main indexes flat as AI optimism ran into worries about geopolitics. Traders now see Swarmer as a high-risk play tied to two stories—battlefield drones and autonomy software, which is software that cuts how much humans have to control the machines.

Shares moved after Jim Cramer talked up Swarmer on “Mad Money,” putting it alongside Red Cat Holdings and AEVEX Aerospace as drone plays. “Swarmer is a natural,” Cramer said. He called it the first Ukrainian defense tech startup and tied the group to federal money for low-cost drones. Insider Monkey

Swarmer develops software to run drone swarms, groups of unmanned aircraft that work together instead of being flown individually. The company says it does not make drones. It sells the “intelligence layer” that controls unmanned systems, and says its product works on different hardware platforms.

That difference is important. Investors have pushed up drone and defense software stocks as governments hunt for cheaper options, but Swarmer is still in its early stages. Revenue dropped to $20,325 in the first quarter from $110,704 a year ago. Net loss grew to $4.46 million from $693,977, according to the company’s May report.

Swarmer is looking to new contracts to move from battlefield use to commercial sales. The company said on May 13 that Meta Bureau LLC gave Swarmer Estonia OÜ a $2.86 million contract to supply more than 16,000 software licenses for SkyKnight quadcopter bombers and other UAVs. There are options that could boost the deal by another $10.4 million. Global CEO Serhii Kupriienko said, “integrating our software with SkyKnight and other UAVs.” Swarmer

Swarmer is pitching its software as a fix for the growing use of drones and a lack of operators, President and U.S. CEO Alex Fink said. “Swarmer’s software is purpose-built for this environment,” Fink told investors on first-quarter results.

Swarmer said in May it is working with X-Drone, Norda Dynamics and Kara Dag Technologies to build a drone-interceptor system that can be deployed quickly. Non-executive Chairman Erik Prince said the group wants a site-defense kit that fits in a container and can be moved and put in place in under a day.

Competitive pressures remain tight and lopsided. Red Cat, one of the public drone firms Cramer mentioned, is heavier on hardware. Private maker AEVEX is another player. Swarmer is pitching something else—it’s aiming to plug into several drone platforms instead of making or owning a single airframe.

Swarmer’s rally faces some tests. Contract options might go unused, and procurement can take time. The company’s filings flag risk, saying future results depend on building up new customer deals as revenue from its top Ukrainian client drops off. As of March 31, Swarmer had $23.5 million in cash and an accumulated deficit of $15.1 million, according to a filing.

Swarmer started trading on Nasdaq in March, pricing its IPO at $5 a share. On Tuesday, the stock closed above 15 times that level. The move has turned the young, unprofitable defense software company into a momentum name in the market.

Latest articles

Swarmer Soars 38% After Cramer Shouts Out Drone Software

Swarmer Soars 38% After Cramer Shouts Out Drone Software

2 June 2026
Swarmer soared 37.7% to $78.52 after Jim Cramer called it “a natural” on “Mad Money,” sparking retail and drone investor interest despite shrinking revenue, widening losses, and execution risks around defense contracts; shares now trade over 15 times their March IPO price.
Abivax Shares Drop After Trial Win and Cancer Cases Raise Concerns

Abivax Shares Drop After Trial Win and Cancer Cases Raise Concerns

2 June 2026
Abivax shares plunged 44% to €63.10 after strong Phase 3 results for obefazimod in ulcerative colitis were overshadowed by cancer and dysplasia cases in the high-dose arm, which investigators deemed unrelated to treatment, raising investor concerns over safety and regulatory risk despite meeting all efficacy endpoints.
Netflix Stock Sinks, Wall Street Turns to June 4

Netflix Stock Sinks, Wall Street Turns to June 4

2 June 2026
Netflix shares slid nearly 3% to $83.36 as investors questioned growth targets ahead of Thursday’s annual meeting, with the stock under pressure despite management maintaining 2026 revenue and margin forecasts and warning of heavier content costs in the first half.
Marathon Digital Drops as Bitcoin Tops $70,000; Eyes on AI Push

Marathon Digital Drops as Bitcoin Tops $70,000; Eyes on AI Push

2 June 2026
MARA fell 4.2% to $14.23 as bitcoin slid below $70,000, highlighting the miner’s ongoing dependence on crypto prices despite efforts to pivot toward AI and power infrastructure; analysts remain split on the new strategy, and the Long Ridge deal still faces regulatory and execution risks.
Dow, S&P inch up as AI surge faces $80 billion hurdle

Dow, S&P inch up as AI surge faces $80 billion hurdle

2 June 2026
Alphabet shares fell after announcing plans to raise $80 billion through equity offerings to fund soaring AI infrastructure costs, even as demand for its AI services exceeded supply and capital spending forecasts climbed to $180–$190 billion for 2026.
Dow Jones Moves Up in Late Trading

Dow Jones Moves Up in Late Trading

2 June 2026
Dow Jones rose 0.29% to 51,227.89 as AI-driven buying offset inflation and rate risks; Alphabet shares fell after boosting 2026 capital spending to $180–$190 billion and seeking $80 billion in equity, raising questions about funding the AI boom, while investors await Friday’s payrolls report for the next market signal.
Abivax Shares Drop After Trial Win and Cancer Cases Raise Concerns
Previous Story

Abivax Shares Drop After Trial Win and Cancer Cases Raise Concerns

Go toTop